EMA — authorised 26 March 2021
- Marketing authorisation holder: Amarin Pharmaceuticals Ireland Limited
- Status: approved
🇪🇺 Vascepa in European Union
EMA authorised Vascepa on 26 March 2021
Marketing authorisation
Vascepa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Vascepa approved in European Union?
Yes. EMA authorised it on 26 March 2021.
Who is the marketing authorisation holder for Vascepa in European Union?
Amarin Pharmaceuticals Ireland Limited holds the EU marketing authorisation.